GE HealthCare Technologies (NASDAQ:GEHC) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

GE HealthCare Technologies (NASDAQ:GEHC) had its price target boosted by analysts at Stifel Nicolaus from $90.00 to $95.00 in a report issued on Wednesday, Marketbeat reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 7.76% from the stock’s previous close.

Several other equities research analysts also recently issued reports on GEHC. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Jefferies Financial Group lifted their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Barclays began coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target on the stock. Wells Fargo & Company lowered their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Finally, Bank of America upped their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday. Seven research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $88.17.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $88.16 on Wednesday. The firm has a market capitalization of $40.16 billion, a PE ratio of 18.21, a price-to-earnings-growth ratio of 3.34 and a beta of 1.08. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80. The stock’s 50 day moving average price is $80.05 and its 200 day moving average price is $76.55. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter last year, the company earned $1.14 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of institutional investors have recently made changes to their positions in GEHC. Thoma Capital Management LLC lifted its stake in GE HealthCare Technologies by 1.4% during the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the last quarter. Glenview Trust co raised its holdings in shares of GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after purchasing an additional 139 shares during the period. True North Advisors LLC lifted its position in shares of GE HealthCare Technologies by 2.0% in the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after buying an additional 139 shares during the last quarter. Klingman & Associates LLC boosted its holdings in shares of GE HealthCare Technologies by 4.0% in the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after buying an additional 139 shares during the period. Finally, Colonial Trust Advisors grew its position in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after buying an additional 139 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.